Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies
- 1 August 2015
- journal article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 30, 57-63
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Neuronal Surface and Glutamic Acid Decarboxylase Autoantibodies in Nonparaneoplastic Stiff Person SyndromeJAMA Neurology, 2013
- Neuropsychological course of voltage‐gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitisEuropean Journal of Neurology, 2013
- Autoantibodies associated with diseases of the CNS: new developments and future challengesThe Lancet Neurology, 2011
- Limbic encephalitis in children and adolescentsArchives of Disease in Childhood, 2010
- Antibodies to glutamic acid decarboxylase define a form of limbic encephalitisAnnals of Neurology, 2010
- Acute limbic encephalitis and glutamic acid decarboxylase antibodies: A reality?Journal of the Neurological Sciences, 2009
- Limbic encephalitis associated with anti‐GAD antibody and common variable immune deficiencyDevelopmental Medicine & Child Neurology, 2009
- Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodiesJournal of Neuroimmunology, 2008
- Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseasesAnnals of Neurology, 2007
- Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase AntibodiesArchives of Neurology, 2001